LoMyo Myopia Control ⋆ Goodrich Optical

Revolutionizing Myopia Management for Kids

Designed with cutting-edge technology and backed by extensive research, LoMyo lenses offer an exciting new approach to treating the “silent pandemic” of childhood myopia.

This lens is not only extremely effective in slowing the rate of myopia increase: it also combats ocular elongation thanks to its unique Myo Free-form Technology, which adapts to the nasal and temporal asymmetry of the retina.

In clinical trials, wearers of this new lens had an astonishing 39% decrease in axial length change, after 12 months, compared to wearers of traditional single vision lenses.

Manufactured with free-form technology, LoMyo lenses from Goodrich Optical are compatible with any standard frame style. They are also aesthetically pleasing, with no trace of the treatment showing on the lens.

Who is LoMyo for?

According to a worldwide study, children with a refractive error of -0.50D to -1.00D and at least 6 years of age are suitable candidates for LoMyo lenses.

Myopia often begins to develop during school years. It has been demonstrated that its onset at early ages, is a precursor for high myopia in the future. Prompt treatment is crucial to limit the chances of progression. Treatment should start as soon as the first symptoms of myopia appear.

Theoretical Foundation

The LoMyo myopia management lens is based on hyperopic defocus theory. Traditional minus lenses cause light to focus behind the peripheral retinal plane. This can stimulate the eye to elongate and worsen the myopia over time. By contrast, a lens with positive power in the periphery enables light to focus correctly on the retinal plane.

Myo Free-Form Technology

Myo Free-Form Technology is an advanced innovation that effectively slows the progression of axial elongation in a child’s eyes. This is achieved by incorporating asymmetric positive defocus on the back surface of the lens, which is calibrated to the natural asymmetry of the retina. This ensures that all light is focused directly on the retinal plane, effectively combating ocular elongation, and slowing the progression of myopia.

Myo Free-Form Technology includes two zones. In the center is a clear visual zone, with an ovoidal shape that improves vision on the vertical axis.

Surrounding this first zone, there is the myopia treatment zone with asymmetric peripheral defocus, strategically calibrated for each child. These carefully calculated zones give children the best possible visual experience while simultaneously treating their myopia progression.

Proven Clinical Trial Results

The efficacy of LoMyo lenses has been evaluated in the first randomized, double-blind study. Children aged 6-12 took part, with treatment continuing for one year.

The study yielded remarkable preliminary results. Ocular elongation, measured by axial length increase, was an astonishing 39% lower after 12 months in wearers of this lens compared to a standard single vision lens.

Analysis shows that wearers of our innovative lens technology experience significantly less ocular elongation compared to those using single vision lenses.

Notably, the satisfaction scores were found to be on par with those achieved using a single vision lens, underscoring the seamless adaptability of children to our innovative lens solution.